Drug Research
Indian government starts talks to procure COVID-19 vaccine
Covid-19 vaccines being developed by UK’s Oxford-AstraZeneca and United States’s Moderna-NIAID are the top candidates India is looking at for possible acquisition discussions, senior government officials aware of the country’s vaccine strategy said, adding that a group of experts...
News
Liveo Research Expands Pharma Packaging Business
Switzerland-based Liveo Research Group, a manufacturer of high-performance barrier films used for blister packaging in the pharmaceutical industry, has announced a 20,000 ton capacity expansion to its existing coating capabilities in Boetzingen, Germany.
With this investment, Liveo will underpin its...
News
Abzena appoints Anu Bansal Ph.D. as Senior Director of Manufacturing at Bristol, Pennsylvania facility
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania.
With more than...
News
Lee Pharma to launch favipiravir under brand name Faravir
Lee Pharma has received DCGI’s approval for manufacturing and marketing of active pharmaceutical ingredients (API) for favipiravir in India.
The company also plans to manufacture and market favipiravir medicine, for COVID-19 treatment. Raghu Mitra Alla, Director, Lee Pharma informed that...
Clinical Trials
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. Dr. Shabir Madhi, Professor...
News
Sanofi to acquire Principia Biopharma
Sanofi and Principia Biopharma Inc., a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash,...
News
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will leverage the Oncomine Precision Assay,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.